SCHEMBL1375648

SCHEMBL1375648

O=c1c2ccccc2oc2ccc(CBr)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.50
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
GLA P06280 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
PGAM1 P18669 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ELANE P08246 1/20 0.42
CCR1 P32246 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TTR P02766 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2930770 0.80 MAOA (0.55) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL2763236 0.76 MAOA (0.55) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL544963 0.76 MAOA (0.55) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL3709991 0.71 KDM4E (0.48) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL654368 0.70 KDM4E (0.64) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL30593474 0.70 KDM4E (0.64) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL30641650 0.70 KDM4E (0.64) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL8711806 0.70 MAOA (0.60) MAOAKDM4EALDH1A1HPGDGLA
SCHEMBL4696277 0.70 MAOA (0.90) MAOAKDM4EALDH1A1HPGDGLA
Xanthone SCHEMBL29398266 0.70 MAOA (1.00) MAOAKDM4EALDH1A1HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391610-B1 LUMINESCENT LANTHANIDE COMPLEXES UNIV DURHAM (GB) 2016-10-26 EP disclosed
US-9448225-B2 Responsive luminescent lathanide complexes UNIVERSITY OF DURHAM (GB) 2016-09-20 US disclosed
US-20140179015-A1 RESPONSIVE LUMINESCENT LATHANIDE COMPLEXES UNIVERSITY OF DURHAM (GB) 2014-06-26 US disclosed
US-8628978-B2 Responsive luminescent lanthanide complexes UNIVERSITY OF DURHAM (GB) 2014-01-14 US disclosed
US-8501398-B2 Luminescence assay using macrocyclic lanthanide (III) complexes UNIVERSITY OF DURHAM (GB) 2013-08-06 US disclosed
US-20110287558-A1 RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES UNIVERSITY OF DURHAM (GB) 2011-11-24 US disclosed
EP-2041571-B1 LUMINESCENCE ASSAY USING MACROCYCLIC LANTHANIDE (III) COMPLEXES UNIV DURHAM (GB) 2010-09-15 EP disclosed
US-20100055665-A1 LUMINESCENCE ASSAY USING MACROCYCLIC LANTHANIDE (III) COMPLEXES UNIVERSITY OF DURHAM (GB) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179015-A1 RESPONSIVE LUMINESCENT LATHANIDE COMPLEXES GLRX3, SUCNR1, SDHA MAOA 4342/4885KDM4E 532/4885ALDH1A1 511/4885
US-20110287558-A1 RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES GLRX3, SDHA, SUCNR1 MAOA 3792/4885KDM4E 561/4885ALDH1A1 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.